Stanford
Craig Stanford, Albion Park Rail AU
Patent application number | Description | Published |
---|---|---|
20150287006 | Tab Management Method And Apparatus - Apparatus for managing a tab relating to purchases, the apparatus including a sales terminal, a client device and an account server in communication via one or more communications networks. The account server provides an open tab message to the sales terminal, which opens a tab for the user and provides a tab identifier message to the account server. The account server provides an indication of the tab identifier to the client device allowing a user of the client device to present the tab identifier when making a purchase so that the purchase can be added to the tab. The sales terminal provides a tab balance message to the account server, which processes payment of the tab on behalf of the user in accordance with the tab balance and provides payment confirmation to the sales terminal. | 10-08-2015 |
Marianne Stanford, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20090035276 | USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT - The present invention relates to therapeutic use of a combination of Myxoma virus, including in combination with rapamycin. Treatment with rapamycin enhances the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon. The combination of rapamycin and Myxoma virus can be used to treat diseases characterized by the presence of such cells, including cancer. The invention also relates to therapeutic use of Myxoma virus that does not express functional M135R. | 02-05-2009 |
20110195050 | USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT - The present invention relates to therapeutic use of a combination of Myxoma virus, including in combination with rapamycin. Treatment with rapamycin enhances the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon. The combination of rapamycin and Myxoma virus can be used to treat diseases characterized by the presence of such cells, including cancer. The invention also relates to therapeutic use of Myxoma virus that does not express functional M135R. | 08-11-2011 |
20130171106 | USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT - The present invention relates to therapeutic use of a combination of Myxoma virus, including in combination with rapamycin. Treatment with rapamycin enhances the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon. The combination of rapamycin and Myxoma virus can be used to treat diseases characterized by the presence of such cells, including cancer. The invention also relates to therapeutic use of Myxoma virus that does not express functional M135R. | 07-04-2013 |
20140134134 | USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT - The present invention relates to therapeutic use of a combination of Myxoma virus, including in combination with rapamycin. Treatment with rapamycin enhances the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon. The combination of rapamycin and Myxoma virus can be used to treat diseases characterized by the presence of such cells, including cancer. The invention also relates to therapeutic use of Myxoma virus that does not express functional M135R. | 05-15-2014 |
Marianne M. Stanford, Dartmouth, Nova Scotia CA
Patent application number | Description | Published |
---|---|---|
20160067335 | METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER - The present invention provides methods for improving the efficacy of a vaccine in the treatment of cancer. The methods of the invention comprise the administration of at least two doses of an agent that interferes with DNA replication prior to vaccination with a survivin vaccine. Also provided are compositions for use in the methods of the invention. | 03-10-2016 |
Peter Stanford, Murarrie Queensland AU
Patent application number | Description | Published |
---|---|---|
20090125253 | PASSIVE INTERMODULATION TEST APPARATUS - In one aspect of the present invention there is provided a portable test apparatus | 05-14-2009 |
20110224923 | PASSIVE INTERMODULATION TEST APPARATUS - In one aspect of the present invention there is provided a portable test apparatus | 09-15-2011 |
Peter Stanford, Queensland AU
Patent application number | Description | Published |
---|---|---|
20090124122 | Apparatus for Applying A Load - An apparatus for the application of a test load apparatus | 05-14-2009 |
Richard A. Stanford, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20120090849 | HYDRAULIC DISCONNECT - A hydraulic disconnect is disclosed comprising: a downhole housing; an uphole housing; an inner mandrel at least partially disposed telescopically within the downhole housing, the inner mandrel having a latch extendable in a radially outward direction to latch against an inner shoulder of the downhole housing to restrict the downhole housing from relative downhole movement, the inner mandrel being connected for transmission of torque to the downhole housing; a piston at least partially disposed telescopically within the inner mandrel and having a latched position in which an outer surface of the piston is radially inward of the latch to maintain latching against the inner shoulder, and an unlatched position in which a groove in the outer surface is radially inward of the latch to allow radial contraction of the latch into the groove for release of the inner shoulder, the piston having a valve seat; and a lock for maintaining the piston in the latched position, the lock being adapted to unlock in use upon receipt by the valve seat of a disconnect valve member and application of a predetermined hydraulic pressure in a downhole direction against the disconnect valve member to allow the piston to move into the unlatched position; in which the uphole housing has a stop for restricting the downhole housing from relative uphole movement and the inner mandrel is threaded to the uphole housing such that relative rotation between the uphole housing and the downhole housing in use tightens the downhole housing between the latch and the uphole housing. | 04-19-2012 |
William L. Stanford, Toronto CA
Patent application number | Description | Published |
---|---|---|
20100298406 | Method of suppressing tumour growth - A method of suppressing undesirable cell proliferation, such as tumour growth, is provided comprising the step of increasing the level of PCL2 in target cells. | 11-25-2010 |